Picture of CellaVision AB logo

CEVI CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Brief: Cellavision Q1 Sales, EBITDA Fall

April 24 (Reuters) - CellaVision AB CEVI.ST:

CELLAVISION: SOFTER QUARTER DUE TO LOWER SALES IN EMEA

Q1 2026 NET SALES DECREASE 14.6% TO SEK 166 MILLION

Q1 2026 EBITDA SEK 40 MILLION (66)

Q1 2026 EPS SEK 0.94 (1.74)

Source text: ID:nMFN29dBdh

Further company coverage: CEVI.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on CellaVision AB

See all news